MRNA
$34.27
Revenue | $107Mn |
Net Profits | $-971Mn |
Net Profit Margins | -907.48% |
Moderna, Inc.’s revenue fell -35.93% since last year same period to $107Mn in the Q1 2025. On a quarterly growth basis, Moderna, Inc. has generated -88.81% fall in its revenue since last 3-months.
Moderna, Inc.’s net profit jumped 17.36% since last year same period to $-971Mn in the Q1 2025. On a quarterly growth basis, Moderna, Inc. has generated 13.3% jump in its net profits since last 3-months.
Moderna, Inc.’s net profit margin fell -28.98% since last year same period to -907.48% in the Q1 2025. On a quarterly growth basis, Moderna, Inc. has generated -674.6% fall in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -1.81 |
EPS Estimate Current Year | -1.81 |
Moderna, Inc.’s earning per share (EPS) estimates for the current quarter stand at -1.81 - a 38.85% jump from last quarter’s estimates.
Moderna, Inc.’s earning per share (EPS) estimates for the current year stand at -1.81.
Earning Per Share (EPS) | 0 |
Moderna, Inc.’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Moderna, Inc. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2025-07-31 | -2.96 | 0 | 100% |
2025-05-01 | -3.03 | -2.52 | 16.83% |
2025-10-30 | -1.81 | 0 | 100% |